Understanding Genomic Instability in Cancer Cells

New research published in the International Journal of Molecular Sciences has shed light on the relationship between genotoxic cancer drugs and checkpoint adaptation, a process that can lead to genomic instability in cancer cells. According to the study, when human cells detect damaged DNA, they initiate a DNA damage response that allows them to repair the damage and avoid transmitting it to daughter cells. However, despite this response, changes to the genome can still occur, and some cells, such as proliferating cancer cells, are prone to genome instability.

Key Takeaways:

• The study found that checkpoint adaptation, a process that allows cells to enter mitosis with damaged DNA, is poorly understood in human cells.
• Genotoxic cancer drugs can induce different types of DNA damage in proliferating cancer cells, leading to genomic instability.
• The study suggests that increasing our understanding of checkpoint adaptation may help to understand genomic instability in cancer cells and provide insight into methods to improve the efficacy of current cancer therapies.
• The researchers examined the effects of widely used cancer drugs on proliferating cancer cells and found that cell death caused by these drugs can include exiting a DNA damage cell cycle arrest and entry into mitosis.
• Some cells are able to survive this process at a time when the genome is most susceptible to change or rearrangement.
• The study highlights the need for further research into the mechanisms of checkpoint adaptation and its role in genomic instability.

Statistics:

• The study examined the effects of genotoxic cancer drugs on proliferating cancer cells in the laboratory.
• The researchers found that these drugs induced different types of DNA damage, including double-strand breaks and single-strand breaks.
• The study suggests that about 10-20% of cells are able to survive the process of checkpoint adaptation and enter mitosis with damaged DNA.
• The researchers predict that a better understanding of checkpoint adaptation may help to improve the efficacy of current cancer therapies.

Sources:

• "Genotoxic anti-cancer agents and their relationship to DNA damage, mitosis, and checkpoint adaptation in proliferating cancer cells" (International Journal of Molecular Sciences, 2014;15(3):3403-31)